LEVENT HACISÜLEYMAN

Dr. LEVENT HACISÜLEYMAN

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2023 in Canadian Journal of Physiology and Pharmacology
Verified
Journal Article
Closed access
ŞTŞeyma Taştemur
Şeyma Taştemur
LEVENT HACISÜLEYMANLEVENT HACISÜLEYMAN
LEVENT HACISÜLEYMAN
ÖKÖzhan Karataş
Özhan Karataş
FYFatih Yulak
Fatih Yulak
HAHilmi Ataseven
Hilmi Ataseven
Colorectal cancer is the third most lethal and fourth most commonly diagnosed cancer worldwide. Sinapic acid, a derivative of hydroxycinnamic acid, is a promising phytochemical exhibiting numerous pharmacological activities in various systems. It is a substantial chain-breaking antioxidant that operates as a radical scavenger. The aim of this research was to investigate the antiproliferative effect of sinapic acid on the HT-29 cell line besides the mechanisms underlying this activity. The effect of sinapic acid on the viability of HT-29 cell line was investigated using XTT assay. The levels of BCL-2, cleaved caspase 3, BAX, cleaved PARP, and 8-oxo-dG were measured using ELISA. Gamma-H2AX and cytochrome c expressions were assessed semiquantitatively using immunofluorescence staining. Sinapic acid at 200 µm and higher doses produced a significant antiproliferative effect on HT-29 cells. The IC50 value was found to be 317.5 µm for 24 h. Sinapic acid (317.5 µm) significantly elevated cleaved caspase 3, BAX, cleaved PARP, and 8-oxo-dG levels. The levels of gamma-H2AX foci are significantly higher, while the levels of cytochrome c are lower in sinapic acid-treated HT-29 cells. These results indicate that sinapic acid has antiproliferative, apoptotic, and genotoxic effects on colon cancer cells.

27 June 2022 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
LEVENT HACISÜLEYMANLEVENT HACISÜLEYMAN
LEVENT HACISÜLEYMAN
BSBülent Saraç
Bülent Saraç
ZJZiad Joha
Ziad Joha
Drugs that inhibit the reuptake of serotonin, norepinephrine, and/or dopamine are widely used for treating depressive disorders and have emerged as effective drugs for neuropathic pain. They have no substantial anti-nociceptive effects but are considered, with gabapentin/pregabalin, first-line drugs for neuropathic pain. In this study, three different antidepressant agents were used in different doses to investigate their anti-hyperalgesic effects in rat models of neuropathic pain using hot plate and tail flick methods. They have different mechanisms of action; vilazodone hydrochloride is a selective serotonin inhibitor and a 5-HT1A partial agonist; talsupram hydrochloride is a selective noradrenaline inhibitor, and it has a high affinity for noradrenaline transporter (NET), whereas indatraline hydrochloride is a triple reuptake inhibitor that inhibits transporters for 5-HT (SERT), dopamine (DAT), and NET. All the drugs used in the experiment were found to have an anti-hyperalgesic effect in both tests compared to the sham group. When anti-hyperalgesic effects of the three agents were compared to each other, it was found that talsupram hydrochloride was significantly more effective than the two other drugs in hot plate test. However, there was no statistically significant difference in the tail flick test. Indatraline hydrochloride was more effective than vilazodone hydrochloride at the same doses in the tail flick test. Our data suggest that three drugs are effective analgesics in rat models of neuropathic pain and inhibition of noradrenaline reuptake represents the cornerstone of analgesic mechanisms of effective antidepressants.

5 January 2026 in Neurological Research
Verified
Journal Article
Closed access
AÇArzuhan çetindağ
Arzuhan çetindağ
BŞBilal Şahin
Bilal Şahin
LEVENT HACISÜLEYMANLEVENT HACISÜLEYMAN
LEVENT HACISÜLEYMAN
Epilepsy remains a major neurological disorder with high rates of drug resistance and cognitive decline. Repurposing neuroprotective drugs offers a promising approach. Metformin, a widely used antidiabetic agent, has shown anticonvulsant effects, yet its impact on nitric oxide synthase (NOS) isoforms in distinct brain regions remains unclear. Adult male Wistar rats were allocated into control, pentylenetetrazole (PTZ), or metformin+PTZ groups. Metformin (200 mg/kg, i.p.) was administered for 7 days before induction of acute PTZ seizures (45 mg/kg, i.p.). Seizure severity and latency were assessed using Racine's scale, and cognition was evaluated by the passive avoidance test (PAT). Nitric oxide (NO) and the expression of its synthesizing enzymes, inducible (iNOS), neuronal (nNOS), and endothelial (eNOS), were quantified in the cortex and hippocampus via enzyme-linked immunosorbent assay (ELISA). In silico analyses included target prediction and molecular docking to assess metformin - NOS interactions. Metformin significantly reduced seizure severity, prolonged latency to the first myoclonic jerk, and prevented PTZ-induced memory impairment (all p < 0.001). These behavioral effects were accompanied by reductions in cortical and hippocampal nNOS and iNOS expression, decreased cortical eNOS levels, and lower NO accumulation. TargetNet predicted NOS isoforms among potential metformin targets, and docking indicated moderate binding affinity (-5.2 to -5.9 kcal/mol). Metformin exerted seizure-suppressing and cognition-preserving effects in an acute PTZ model, associated with reductions in NOS isoform expression and NO levels, suggesting altered NOS/NO signaling and supporting its potential as an adjunctive candidate for mitigating seizure-related neuronal dysfunction.

26 March 2023 in Cumhuriyet Science Journal
Verified
Journal Article
Open access
PDF file
ZJZıad Joha
Zıad Joha
ŞYŞahin Yıldırım
Şahin Yıldırım
LEVENT HACISÜLEYMANLEVENT HACISÜLEYMAN
LEVENT HACISÜLEYMAN
ATAhmet Şevki Taşkıran
Ahmet Şevki Taşkıran
Despite the fact that narcotics and NSAIDs are the mainstays of nociceptive pain care, only a small proportion of neuropathic pain patients benefit from them. Cannabinoid agents could be a viable alternative to opioids in the management of chronic pain. The goal of our investigation was to assess the analgesic efficacy of SER 601 and L-759,633, cannabinoid receptor 2 (CB2) agonists, at various doses in a model of neuropathic pain generated in rat. The analgesic effect of CB2 agonists L-759,633 and SER 601 at various doses in a rat model of neuropathic pain created by partial sciatic nerve ligation was examined by the hot plate method. Furthermore, a comparison of analgesic effects of both drugs with pregabalin is also conducted. The two substances demonstrated a dose-dependent analgesic effect in this model. The analgesic response of SER601 and L-759,633 in the neuropathic pain model was higher compared to that of pregabalin. All in all, our data suggest that SER601 and L-759,633 may offer a beneficial treatment option for neuropathic pain in future.

27 February 2026 in Anticancer Research
Verified
Journal Article
Closed access
RTRabia Gökçe Takci
Rabia Gökçe Takci
BSBülent Saraç
Bülent Saraç
LEVENT HACISÜLEYMANLEVENT HACISÜLEYMAN
LEVENT HACISÜLEYMAN
BŞBurcu Şahi̇nBaş
Burcu Şahi̇nBaş
ZJZiad Joha
Ziad Joha
Colon and gastric cancers are among the most prevalent gastrointestinal malignancies, often exhibiting poor prognosis due to resistance and recurrence. Polo-like kinase 1 (PLK1), a key regulator of mitosis, is frequently overexpressed in these cancers. BI-2536, a selective PLK1 inhibitor, has shown promising anticancer activity. β-Glucan, a natural immunomodulator, has also demonstrated anticancer potential. This study aimed to evaluate the antiproliferative, apoptotic, and cell cycle effects of BI-2536 alone and in combination with β-glucan on HT-29 colon and AGS gastric cancer cell lines. Cell viability was assessed using the XTT assay. Apoptosis and cell cycle profiles were evaluated using flow cytometry. The combination index (CI) was calculated using the Chou-Talalay method via CompuSyn software. BI-2536 significantly inhibited proliferation and induced G2/M arrest and apoptosis in both cell lines. β-Glucan showed moderate cytotoxicity and enhanced BI-2536's effects. Synergistic antiproliferative activity was observed at lower drug concentrations, such as 2-16 nM BI-2536 combined with 31.25-250 μg/ml β-glucan (CI<1). The combination induced greater apoptosis and more pronounced G2/M arrest compared with either agent alone, demonstrating a clear synergistic effect. BI-2536 in combination with β-glucan exhibits synergistic anticancer effects in vitro, suggesting a promising strategy for treating colon and gastric cancers.

30 April 2026 in European Journal of Multidisciplinary Health Sciences
Verified
Journal Article
Closed access
AÇArzuhan çetindağ
Arzuhan çetindağ
LEVENT HACISÜLEYMANLEVENT HACISÜLEYMAN
LEVENT HACISÜLEYMAN
Epilepsy is a neurological disorder affecting millions of individuals worldwide and remains a major focus of experimental research. The pentylenetetrazole (PTZ)-induced seizure model is widely used in preclinical epilepsy studies; however, its global research landscape has not been systematically evaluated. In this study, a comprehensive bibliometric analysis of PTZ-related epilepsy publications was conducted to identify research trends, influential contributors, and evolving thematic areas. A total of 1,768 original articles published between January 2000 and October 2023 were retrieved from the Scopus database and analyzed using bibliometric tools, including Biblioshiny and VOSviewer, to assess publication output, citation patterns, authorship, institutional and national productivity, and conceptual structure. The results demonstrated a steady growth in PTZ-related publications over time, with China emerging as the leading contributor in terms of publication volume, while Poland showed a high degree of international collaboration. The most cited study was the work by Baraban et al. investigating PTZ-induced behavioral and neural changes in zebrafish. Epilepsy and Behavior, Epilepsy Research, and Epilepsia were identified as the most productive journals in this field. Keyword and thematic analyses revealed frequently studied topics such as oxidative stress, anticonvulsant activity, and neuroinflammation, along with emerging research interests including brain-derived neurotrophic factor and neuronal damage. This study represents the first bibliometric evaluation specifically focused on the PTZ-induced experimental epilepsy model and provides a comprehensive overview of the global research landscape. The findings may assist researchers in recognizing key contributors, identifying research gaps, and guiding future experimental studies in epilepsy.